- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02482987
Comparison of Two Different Alveolar Ridge Preservation Techniques
February 6, 2017 updated by: Brandon Coleman, Eisenhower Army Medical Center
The purpose of this study is to compare two barrier membrane products, Cytoplast (dPTFE) and BioXclude (human amnion chorion allograft), for their relative efficacies in dental socket preservation procedures, both when the socket is filled and overfilled with freeze dried bone allograft (FDBA).
Study Overview
Status
Unknown
Conditions
Detailed Description
This single-blind, randomized clinical trial aims to compare two different, commercially available materials to assess their relative efficacies in socket preservation procedures after tooth extraction.
Patients presenting with single teeth deemed clinically hopeless and treatment planned for removal in the normal course of clinical dentistry will be considered for this study.
If eligible, a ridge/socket preservation procedure will be performed at the time of extraction.
Periodontics residents will perform the procedure under the supervision of board certified staff.
Patients will be randomized via concealed random number sequence into one of four groups, based on a combination of materials and graft placement techniques.
Patients will be equally distributed into the following groups: (1) dense polytetrafluoroethylene (Cytoplast) (2) Cytoplast with additional buccal augmentation/onlay graft, (3) human amniotic-tissue derived membrane (BioXclude), and (4) BioXclude with additional buccal augmentation/onlay graft.
All four treatment groups are consistent with the current standard of care, and this study seeks to compare techniques and materials as part of routine, clinical/periodontal therapy in order to determine superiority.
Approximately 150 patients will be enrolled and distributed equally among the four groups.
Any post-operative complications will be managed and documented during follow-up appointments at 1, 2 and 4 weeks.
Cone beam computed tomography (CBCT) will be used as the primary assessment tool, and scans will be compared between a pre-operative baseline time point and a scan taken after 4 months of healing to prepare for implant placement.
The primary dependent variables will be (1) percent of baseline alveolar ridge changes (both horizontal and vertical) and (2) whether or not the anticipated dental implant could be placed appropriately.
Secondary outcomes include ease of use, perceptions of pain, complications, cost-effectiveness, and changes in keratinized tissue.
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Fort Gordon, Georgia, United States, 30905
- Tingay Dental Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All active duty military patients (age 18-65) referred to the investigators' facility's periodontics department for diagnosis of "hopeless" tooth with documented confirmation of diagnosis by periodontal staff
- Eligible for extraction and ridge preservation (adequately healthy and not otherwise disqualified)
Exclusion Criteria:
- Pregnant or breastfeeding
- History of allergy to involved products
- Current acute infection at the site (chronic periapical infections will not exclude the patient)
- Elian Type 3 extraction sockets
- Sites not treatment planned for implant therapy
- Third molar sites
- American Society of Anesthesiology Category III patients (medically compromised)
- Active duty military patients in a student status
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Cytoplast
Patients will receive ridge preservation procedure with a Cytoplast barrier membrane
|
ridge preservation intervention using the dPTFE membrane device
Other Names:
ridge preservation intervention with additional freeze dried bone allograft (FDBA) placed buccal to the socket
ridge preservation without overlay graft / traditional FDBA placement into the socket only
|
EXPERIMENTAL: BioXclude
Patients will receive ridge preservation procedure with a BioXclude barrier membrane
|
ridge preservation intervention with additional freeze dried bone allograft (FDBA) placed buccal to the socket
ridge preservation without overlay graft / traditional FDBA placement into the socket only
ridge preservation intervention using the dPTFE membrane device
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Alveolar Ridge Width
Time Frame: from baseline to final cone beam CT scan (approximately 4 months)
|
Alveolar ridge dimensional change (horizontal) from Cone beam CT
|
from baseline to final cone beam CT scan (approximately 4 months)
|
Alveolar Ridge Height
Time Frame: from baseline to final cone beam CT scan (approximately 4 months)
|
Alveolar ridge dimensional change (vertical) from cone beam CT
|
from baseline to final cone beam CT scan (approximately 4 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-operative pain perception
Time Frame: 1 week after surgical extraction procedure
|
self-report by patient on visual analog scale
|
1 week after surgical extraction procedure
|
Platform size of implant placed
Time Frame: Implant surgery, approximtely 4 months after baseline
|
Whether or not the originally intended implant size could be placed
|
Implant surgery, approximtely 4 months after baseline
|
Keratinized tissue width (baseline)
Time Frame: pre-op / baseline assessment (after randomization)(prior to time=0)
|
pre-op / baseline assessment (after randomization)(prior to time=0)
|
|
Keratinized tissue width (final)
Time Frame: from pre-op assessment at time of randomization to implant surgery (4 months)
|
from pre-op assessment at time of randomization to implant surgery (4 months)
|
|
Elian classification (anticipated)
Time Frame: pre-op / baseline assessment (after randomization)(prior to time=0)
|
Operators will report an anticipated socket preservation classification according to Elian 2007
|
pre-op / baseline assessment (after randomization)(prior to time=0)
|
Elian classification (actual)
Time Frame: intra-operative surgical finding (extraction surgery)(time=0)
|
Operators will report the actual socket preservation classification according to Elian 2007
|
intra-operative surgical finding (extraction surgery)(time=0)
|
Buccal plate thickness
Time Frame: intra-operative surgical finding (extraction surgery)(time = 0)
|
intra-operative measurements, presence or absence of a dehiscence / fenestration
|
intra-operative surgical finding (extraction surgery)(time = 0)
|
Buccal plate fenestration
Time Frame: intra-operative surgical finding (extraction surgery)(time = 0)
|
determined at time of extraction surgery, and noted as a possible confounding variable
|
intra-operative surgical finding (extraction surgery)(time = 0)
|
Complications after surgery (infection)
Time Frame: 0-4 months
|
infection, determined by presence of purulence, lymphadenopathy and/or febrile status
|
0-4 months
|
Complications after surgery (membrane exfoliation)
Time Frame: 0-4 months
|
dichotomous variable, presence or absence of the membrane for the duration of the study
|
0-4 months
|
Peri-operative clinician's report (extraction difficulty)
Time Frame: intra-operative surgical finding (extraction surgery)
|
subjective extraction difficulty, as reported by the clinician
|
intra-operative surgical finding (extraction surgery)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sedation utilization
Time Frame: intra-operative surgical variable (determined in advance, at baseline)
|
presence or absence of sedation drugs during the procedure
|
intra-operative surgical variable (determined in advance, at baseline)
|
Cost
Time Frame: 0-4 months
|
cost/benefit for each product
|
0-4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Brandon Coleman, DDS,MS, US Army Fort Gordon DENTAC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2015
Primary Completion (ANTICIPATED)
July 1, 2018
Study Completion (ANTICIPATED)
July 1, 2018
Study Registration Dates
First Submitted
June 19, 2015
First Submitted That Met QC Criteria
June 25, 2015
First Posted (ESTIMATE)
June 26, 2015
Study Record Updates
Last Update Posted (ESTIMATE)
February 7, 2017
Last Update Submitted That Met QC Criteria
February 6, 2017
Last Verified
February 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 408953-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Loss of Teeth Due to Extraction
-
Cairo UniversityNot yet recruitingLoss of Teeth Due to ExtractionEgypt
-
The University of Texas Health Science Center at...Osteogenics BiomedicalCompletedLoss of Teeth Due to Extraction
-
Proed, Torino, ItalyCompletedEdentulous Alveolar Ridge | Loss of Teeth Due to ExtractionItaly
-
Tufts UniversityCompletedLoss of Teeth Due to ExtractionUnited States
-
Rui FigueiredoMTS Europe GmbH (sponsor)WithdrawnBone Resorption | Loss of Teeth Due to ExtractionSpain
-
Implantology InstituteUnknownBone Resorption | Alveolar Bone Loss | Loss of Teeth Due to ExtractionPortugal
-
Universidad Complutense de MadridNORICUM SLRecruitingEdentulous Alveolar Ridge | Alveolar Bone Loss | Loss of Teeth Due to ExtractionSpain
-
William GiannobileJohnson & Johnson; OraPharmaCompletedEdentulous Alveolar Ridge | Alveolar Bone Loss | Loss of Teeth Due to ExtractionUnited States
-
Astellas Pharma Global Development, Inc.TerminatedReduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen ExtractionUnited States
-
Taibah UniversityCompletedDental Extraction | Overcoming the Failure of Anaesthesia | Maxillary TeethSaudi Arabia
Clinical Trials on dense polytetrafluoroethylene (dPTFE) membrane Cytoplast
-
Indiana UniversitySnoasis Medical ProductsCompletedPathological Conditions, Anatomical | Alveolar Bone Loss
-
University of LouisvilleCompleted
-
Firas Al YafiCompletedTooth Extraction | Alveolar Ridge PreservationUnited States
-
Hams Hamed AbdelrahmanCompletedSoft Tissue HealingEgypt
-
Saint-Joseph UniversityCompleted